A novel – and rapid – anti-cancer drug development strategy has resulted in a new drug that stops kidney and pancreatic tumors from growing in mice. Researchers at the Moores Cancer Center at the University of California, San Diego, have found a drug that binds to a molecular “switch” found in [...]

We all have at one time or another experienced the typical signs of an infection: the fever, the listlessness, the lack of appetite. They are orchestrated by the brain in response to circulating cytokines, the signaling molecules of the immune system. But just how cytokines’ reach extends beyond the almost impenetrable blood-brain barrier has been [...]

Spectrum Pharmaceuticals (NasdaqGM: SPPI) today announced that the second of two Phase 3 pivotal clinical trials of apaziquone has achieved its enrollment target. The two trials enrolled more than 1600 patients with non-muscle invasive bladder cancer. As per the collaboration agreement with Allergan, a $1.5 million milestone payment will be paid to Spectrum Pharmaceuticals.

A new study claims that some older people with mild memory-loss are three times more likely to develop dementia if they also have diabetes.
The research, by Alzheimer’s Research Trust scientists at King’s College London, published in the British Journal of Psychiatry, investigated the connection between mild cognitive impairment (MCI) in older people and dementia.

Researchers have identified a key epigenetic mechanism in the brain that helps explain cocaine’s addictiveness, according to research funded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health.